Duke lands big federal grant for HIV/AIDS research

knordstrom@newsobserver.comJuly 11, 2012 

— Duke University has been awarded a seven-year federal grant worth of up to $139 million to fund research aimed at creating effective HIV vaccines.

Duke will receive $19.9 million in the first year of the grant, which is funded by the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health.

Worldwide, more than 7,000 people are infected with HIV each day. More than 1 million people are infected with HIV in the United States, with 20 percent unaware of their infection.

“Today’s grant reaffirms our nation’s commitment to HIV/AIDS research and underscores the Triangle’s prominent role in this groundbreaking science,” U.S. Rep. David Price, a Democrat from Chapel Hill, said in a statement Wednesday. “This award brings much hard work to fruition and is a testament to the quality of researchers and research programs at Duke. It is particularly exciting to focus on vaccine development, which may put us on a path to eradication of this devastating disease.”

The research will focus on understanding so-called broadly neutralizing antibodies, which may be the key to an effective HIV vaccine.

Vaccines prevent disease by tricking our bodies into making antibodies – the exterminators of the immune system. Antibodies are proteins that weed out intruders such as viruses and bacteria, and ours are generally helpless against HIV, which causes AIDS.

But a tiny percentage of HIV-infected people are found to make broadly neutralizing antibodies. They are broad in that they can stamp out different strains of HIV. Such breadth is necessary for a universal vaccine as no one can know which strain they may encounter.

The grant creates a center at Duke University, named the Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery. A second CHAVI-ID site was selected at the Scripps Research Institute in La Jolla, Calif.

Dr. Barton Haynes will direct the Duke CHAVI-ID. Haynes, a professor of medicine and immunology, has studied HIV for more than 22 years and was director of Duke’s previous HIV center, the Center for HIV/AIDS Vaccine Immunology.

The Duke center will collaborate with partners from Oxford University in England, the University of Pennsylvania, Los Alamos National Laboratory and Harvard University.

Nordstrom: 919-829-8983

News & Observer is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service